2002
Search results
Doug Cole joined Flagship Pioneering in 2001. He focuses on life science. At Flagship, Doug has co-founded Ensemble Therapeutics, Foghorn Therapeutics (NASDAQ: FHTX), Inzen Therapeutics, Moderna (NASDAQ: MRNA), Permeon Biologics, Sigilon Therapeutics, (NASDAQ: SGTX), and Syros Pharmaceuticals (NASDAQ: SYRS).
- What Is The Fellowship?
- What Are Their Beliefs?
- Why Is It So Influential?
- Where Do They Get Their Money from?
- What Have Others Said About The Group?
The Fellowship Foundationcan be traced back to 1934, when its founder, a Norwegian Methodist clergyman called Abraham Vereide, started hosting prayer meetings in San Francisco. He was also said to be a social innovator, and he set up a system in which the unemployed could repair old clothing and furniture in a bid to earn money, and The Fellowship ...
According to their mission statement its aim is: “To develop and maintain an informal association of people banded together, to go out as “ambassadors of reconciliation,” modelling the principles of Jesus, based on loving God and loving others. To work with the leaders of many nations, and as their hearts are touched, the poor, the oppressed, the w...
In 1953, Douglas Coe, who was working alongside Vereide, founded the National Prayer Breakfast. The religious event has since taken place in Washington DC every year, and every President since Dwight D. Eisenhower has attended. Sharlet says in the docuseries that Coe’s development of the event was to create a “public ritual”. “Their idea was that t...
The Fellowship Foundation, which since 1935 has conducted no public fundraising programs, relies totally on private donations. In 2007, the group received nearly $16.8 million to support their 400 ministries.
The New Yorkercalled it “like a Frat House for Jesus”. Jeff Sharlet, who wrote the book that the series is based on says: “The Fellowship is the darkest expression of religious life that I’ve found in 20 years.” D. Michael Lindsay, a sociologist who studies the evangelical movement, said “there is no other organisation like the Fellowship, especial...
Doug Cole joined Flagship Pioneering in 2001. He focuses on life science. He holds an A.B. magna cum laude with high distinction in English from Dartmouth College, where he was a senior fellow and a member of Phi Beta Kappa, and an M.D. from the University of Pennsylvania School of Medicine, where he was a member of Alpha Omega Alpha.
Mar 2, 2022 · Vesalius Therapeutics Flagship Pioneering Emerging Biopharma funding series A Venture Capital Biotech. When Christopher Austin, M.D., and Doug Cole, M.D., were co-residents at Massachusetts ...
- Kyle Lahucik
Mar 2, 2022 · Co-Founded by Doug Cole, M.D., Managing Partner at Flagship Pioneering, and Christopher Austin, M.D., former Director of the National Center for Advancing Translational Sciences (NCATS) within the National Institutes of Health (NIH), who will lead the company as CEO.
At Flagship, Doug has co-founded Ensemble Therapeutics, Permeon Biologics, Moderna (NASDAQ: MRNA), Syros Pharmaceuticals (NASDAQ: SYRS), Sigilon Therapeutics, and Foghorn Therapeutics.
People also ask
Who is Doug Cole?
Who is Craig Cole?
Who is Doug Smith?
Entrepreneur, investor, founder, venture capitalist, physician. <br><br>Since 2001, I… · Experience: Flagship Pioneering · Education: Dartmouth College · Location: Cambridge · 500+ connections on...
- Flagship Pioneering
